Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000658271 | SCV000780042 | uncertain significance | not provided | 2018-05-18 | criteria provided, single submitter | clinical testing | A variant of uncertain significance has been identified in the SCN9A gene. The I999V variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The I999V variant is observed in 7/23618 (0.03%) alleles from individuals of African background (Lek et al., 2016). The I999V variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. In-silico analyses, including protein predictors and evolutionary conservation, support that this variant does not alter protein structure/function. Based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |
Labcorp Genetics |
RCV001210899 | SCV001382410 | likely benign | Neuropathy, hereditary sensory and autonomic, type 2A; Generalized epilepsy with febrile seizures plus, type 7 | 2024-10-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003163031 | SCV003893454 | uncertain significance | Inborn genetic diseases | 2023-02-21 | criteria provided, single submitter | clinical testing | Unlikely to be causative of SCN9A-related neuropathic pain syndromes (AD) Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |